lcp
We have detected you are using Internet Explorer. To provide the best and most secure experience, please use a modern browser as we do not support Internet Explorer.
Blog post branding logo

Medcast makes a new home for quality use of medicines education

25 March 2024 - Quality Use of Medicines Alliance

Medcast has launched QHUB, an innovative new platform dedicated to quality use of medicines education. The initiative marks a significant milestone for the Quality Use of Medicines Alliance - a consortium spearheaded by Medcast and Health Care Consumers Association and funded by the Australian Government through the Quality use of Diagnostics, Therapeutics and Pathology Program.

QHUB represents one of the most substantial quality use of medicines education initiatives since the discontinuation of NPS MedicineWise in 2022. 

Over the next 2 years QHUB will provide invaluable support to healthcare professionals across 4 priority health areas, with an initial focus on eczema, followed by gout, antidepressants in older people and anticoagulants. 

A pivotal resource, QHUB will empower health professionals to enhance patient outcomes. It offers a comprehensive range of free, innovative, evidence-informed activities and resources including virtual educational visits, live webinars, podcasts, peer group learning and health professional mediated consumer resources.

 

 A/Prof Dr Stephen Barnett Managing Director at Medcast

Facilitated through the Quality Use of Medicines Alliance, QHUB brings together quality use of medicines expertise, researchers, education providers, colleges, peak bodies and consumer groups. This collaborative approach emphasises the integration of consumer and healthcare professional perspectives at every stage of development.

Darlene Cox, Executive Director at Health Care Consumers Association highlighted the program's co-design principles and said 

‘This program exemplifies co-design in action, with consumers and healthcare professionals collaborating to design, develop, and deliver evidence-based resources to improve health outcomes for consumers and carers’.

 

QHUB’s launch is timely, commencing with a focus on eczema, a condition affecting approximately 2.8 million Australians including 1 in 3 children aged under 6. Despite being often perceived as a minor ailment, eczema poses significant challenges for patients, impacting their quality of life and mental well-being. Moreover, the condition incurs substantial costs to the healthcare system, exceeding $593 million in 2019-2020¹. 

Patients and carers encounter inconsistent information from different health professionals, which leaves them confused, less likely to adhere to foundational and first-line therapy, and more open to information from less reliable sources, such as social media. And with health professionals facing limited time and ready access to supporting resources for eczema, there can be significant variations in practice and communication with patients.

The launch of QHUB signifies a crucial step towards addressing quality use of medicines challenges and fostering collaboration between healthcare professionals and consumers.

For media inquiries and further information, please contact: 

Kate Clutton
M: 0407 580 929
E: kate.clutton@medcast.com.au



Reference
¹https://www.eczemasupport.org.au/national-strategy/

 

Quality Use of Medicines Alliance
Quality Use of Medicines Alliance

The Quality Use of Medicines Alliance a consortium of eight health and consumer organisations, will align their work across the two grants, awarded under the Australian Government’s Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program.  

FOLLOW QHUB

Receive QHUB updates to your inbox.

Or follow us on social media

Related Tags
Related Categories
Related News
Scratching the Surface: Jack Steele on Living with Eczema

Jarrah Anderson

Brand icon

Join Jack Steele as he shares his journey with severe eczema, discussing challenges and strategies for managing the condition. A must-listen for those seeking support and insights.

30 mins READ
Gout in Focus: Why is it important and how do we achieve better outcomes?

Dr Kate Annear

Brand icon

Join Dr Kate Annear as she discusses Gout with Professor Ric Day, a highly experienced rheumatologist and clinical pharmacologist. This podcast will cover why gout is important, and will also address some of the common misconceptions surrounding this condition as well as providing some practical advice on supporting better outcomes in the management of this condition.

30 mins READ
Managing gout in 2024 – are you up to date?

Dr Kate Annear

Brand icon

Gout, a chronic inflammatory condition, is often undertreated despite its impact on quality of life. Misconceptions include it being only a lifestyle disease or affecting only older men. Effective management requires lifelong urate-lowering therapy and addressing both pharmacologic and non-pharmacologic factors.

5 mins READ